FREE PSA AND CLINICALLY SIGNIFICANT ANDFATAL PROSTATE CANCER IN THE PLCO SCREENING TRIAL

被引：0
|
作者：
Yim, Kendrick
Ma, Chaoran
Carlsson, Sigrid
Lilja, Hans
D'Andrea, Vincent
Mucci, Lorelei
Penney, Kathryn
Preston, Mark
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD38-09
引用
收藏
页码：E996 / E997
页数：2
相关论文
共 50 条
  • [1] Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial
    Yim, Kendrick
    Ma, Chaoran
    Carlsson, Sigrid
    Lilja, Hans
    Mucci, Lorelei
    Penney, Kathryn
    Kibel, Adam S.
    Eggener, Scott
    Preston, Mark A.
    JOURNAL OF UROLOGY, 2023, 210 (04): : 630 - 637
  • [2] FAMILY HISTORY AND INCREASED RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN THE PLCO CANCER SCREENING TRIAL
    Bernstein, Adrien
    Golan, Ron
    Shoag, Jonathan
    Dinerman, Brian
    Hu, Jim C.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E897 - E897
  • [3] Body mass index and impact on PSA screening and prostate cancer detection in the PLCO trial
    Grubb, RL
    Levin, DL
    Pinsky, PF
    Mabie, J
    Riley, TL
    Greenlee, R
    Urban, DA
    Ragard, LR
    Crawford, ED
    Andriole, GL
    JOURNAL OF UROLOGY, 2006, 175 (04): : 155 - 155
  • [4] PATTERN OF PSA CHANGE DURING SERIAL SCREENING IN THE PLCO CANCER SCREENING TRIAL AFFECTS PROSTATE CANCER RISK
    Grubb, Robert L., III
    Black, Amanda
    Reding, Douglas
    Hickey, Thomas
    Pinsky, Paul F.
    Church, Timothy R.
    Izmirlian, Grant
    Riley, Thomas
    Mabie, Jerome
    Ragard, Lawrence R.
    Berg, Christine D.
    Prorok, Philip C.
    Crawford, E. David
    Andriole, Gerald L., Jr.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 811 - 812
  • [5] Evidence for clinically significant prostate cancer, overdiagnosis, active surveillance, and PSA screening
    Takahashi, Takeshi
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [6] LETHAL PROSTATE CANCER IN THE PLCO CANCER SCREENING TRIAL
    Shoag, Jonathan
    Mittal, Sameer
    Halpem, Joshua
    Scherr, Douglas
    Hu, Jim
    Barbieri, Christopher
    JOURNAL OF UROLOGY, 2016, 195 (04): : E390 - E390
  • [7] Lethal Prostate Cancer in the PLCO Cancer Screening Trial
    Shoag, Jonathan
    Mittal, Sameer
    Halpern, Joshua A.
    Scherr, Douglas
    Hu, Jim C.
    Barbieri, Christopher E.
    EUROPEAN UROLOGY, 2016, 70 (01) : 2 - 5
  • [8] Impact of PSA screening on mortality - PLCO Project Team (Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial)
    Heidenreich, A.
    Nitschmann, S.
    INTERNIST, 2010, 51 (02): : 219 - 220
  • [9] PSA VARIABILITY AND THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER
    Vilson, Fernandino
    Zhang, Boya
    Brooks, James
    Osborne, Thomas
    Ray, Priyadip
    Leppert, John
    JOURNAL OF UROLOGY, 2021, 206 : E501 - E501
  • [10] Re: Lethal Prostate Cancer in the PLCO Cancer Screening Trial
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 196 (06): : 1677 - 1677
12345